nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Methotrexate—hematologic cancer	0.368	1	CrCtD
Pralatrexate—SLC19A1—Methotrexate—hematologic cancer	0.0781	0.346	CbGbCtD
Pralatrexate—FPGS—Methotrexate—hematologic cancer	0.0565	0.25	CbGbCtD
Pralatrexate—Leucovorin—Methotrexate—hematologic cancer	0.0484	0.2	CrCrCtD
Pralatrexate—Tetrahydrofolic acid—Methotrexate—hematologic cancer	0.0484	0.2	CrCrCtD
Pralatrexate—Folic Acid—Methotrexate—hematologic cancer	0.0484	0.2	CrCrCtD
Pralatrexate—Raltitrexed—Methotrexate—hematologic cancer	0.0484	0.2	CrCrCtD
Pralatrexate—Pemetrexed—Methotrexate—hematologic cancer	0.0484	0.2	CrCrCtD
Pralatrexate—TYMS—Gemcitabine—hematologic cancer	0.0423	0.188	CbGbCtD
Pralatrexate—DHFR—Methotrexate—hematologic cancer	0.0287	0.127	CbGbCtD
Pralatrexate—TYMS—Methotrexate—hematologic cancer	0.02	0.0885	CbGbCtD
Pralatrexate—SLC19A1—hematopoietic system—hematologic cancer	0.00256	0.0993	CbGeAlD
Pralatrexate—SLC19A1—gonad—hematologic cancer	0.00195	0.0755	CbGeAlD
Pralatrexate—FPGS—hematopoietic system—hematologic cancer	0.00171	0.0662	CbGeAlD
Pralatrexate—SLC19A1—blood—hematologic cancer	0.0017	0.0658	CbGeAlD
Pralatrexate—SLC19A1—lung—hematologic cancer	0.00149	0.0577	CbGeAlD
Pralatrexate—SLC19A1—testis—hematologic cancer	0.0014	0.0544	CbGeAlD
Pralatrexate—FPGS—blood—hematologic cancer	0.00113	0.0439	CbGeAlD
Pralatrexate—TYMS—hematopoietic system—hematologic cancer	0.00112	0.0434	CbGeAlD
Pralatrexate—DHFR—hematopoietic system—hematologic cancer	0.00111	0.043	CbGeAlD
Pralatrexate—SLC19A1—lymph node—hematologic cancer	0.00102	0.0395	CbGeAlD
Pralatrexate—FPGS—lung—hematologic cancer	0.000991	0.0384	CbGeAlD
Pralatrexate—FPGS—testis—hematologic cancer	0.000935	0.0363	CbGeAlD
Pralatrexate—Tetrahydrofolic acid—FTCD—hematologic cancer	0.000931	0.347	CrCbGaD
Pralatrexate—TYMS—gonad—hematologic cancer	0.000851	0.033	CbGeAlD
Pralatrexate—DHFR—gonad—hematologic cancer	0.000842	0.0327	CbGeAlD
Pralatrexate—TYMS—blood—hematologic cancer	0.000741	0.0288	CbGeAlD
Pralatrexate—DHFR—blood—hematologic cancer	0.000734	0.0285	CbGeAlD
Pralatrexate—TYMS—bone marrow—hematologic cancer	0.000717	0.0278	CbGeAlD
Pralatrexate—DHFR—bone marrow—hematologic cancer	0.00071	0.0276	CbGeAlD
Pralatrexate—FPGS—lymph node—hematologic cancer	0.000678	0.0263	CbGeAlD
Pralatrexate—TYMS—lung—hematologic cancer	0.00065	0.0252	CbGeAlD
Pralatrexate—DHFR—lung—hematologic cancer	0.000644	0.025	CbGeAlD
Pralatrexate—TYMS—testis—hematologic cancer	0.000613	0.0238	CbGeAlD
Pralatrexate—DHFR—testis—hematologic cancer	0.000607	0.0236	CbGeAlD
Pralatrexate—TYMS—lymph node—hematologic cancer	0.000445	0.0172	CbGeAlD
Pralatrexate—Pemetrexed—DCK—hematologic cancer	0.000442	0.165	CrCbGaD
Pralatrexate—DHFR—lymph node—hematologic cancer	0.00044	0.0171	CbGeAlD
Pralatrexate—Tetrahydrofolic acid—MTR—hematologic cancer	0.000307	0.115	CrCbGaD
Pralatrexate—Leucovorin—ABCC3—hematologic cancer	0.000257	0.0958	CrCbGaD
Pralatrexate—TYMS—Nilotinib—Imatinib—hematologic cancer	0.000252	0.139	CbGdCrCtD
Pralatrexate—Folic Acid—ABCC3—hematologic cancer	0.000165	0.0618	CrCbGaD
Pralatrexate—TYMS—Vitamin A—Alitretinoin—hematologic cancer	0.000152	0.0837	CbGdCrCtD
Pralatrexate—Methotrexate—ABCC3—hematologic cancer	0.000113	0.0422	CrCbGaD
Pralatrexate—TYMS—Isotretinoin—Alitretinoin—hematologic cancer	0.000106	0.0585	CbGdCrCtD
Pralatrexate—TYMS—Tretinoin—Alitretinoin—hematologic cancer	0.000106	0.0585	CbGdCrCtD
Pralatrexate—TYMS—Podofilox—Teniposide—hematologic cancer	0.000106	0.0583	CbGdCrCtD
Pralatrexate—Folic Acid—MTHFR—hematologic cancer	0.000105	0.0392	CrCbGaD
Pralatrexate—Tetrahydrofolic acid—MTHFR—hematologic cancer	0.000105	0.0392	CrCbGaD
Pralatrexate—Folic Acid—ABCG2—hematologic cancer	8.04e-05	0.03	CrCbGaD
Pralatrexate—TYMS—Menadione—Thalidomide—hematologic cancer	8.03e-05	0.0442	CbGdCrCtD
Pralatrexate—Methotrexate—MTHFR—hematologic cancer	7.18e-05	0.0268	CrCbGaD
Pralatrexate—TYMS—Vincristine—Vinorelbine—hematologic cancer	6.75e-05	0.0371	CbGdCrCtD
Pralatrexate—TYMS—Vinorelbine—Vinblastine—hematologic cancer	6.31e-05	0.0347	CbGdCrCtD
Pralatrexate—TYMS—Vinorelbine—Vincristine—hematologic cancer	6.31e-05	0.0347	CbGdCrCtD
Pralatrexate—TYMS—Podofilox—Etoposide—hematologic cancer	6.3e-05	0.0347	CbGdCrCtD
Pralatrexate—Methotrexate—ABCG2—hematologic cancer	5.5e-05	0.0205	CrCbGaD
Pralatrexate—TYMS—Vinblastine—Vinorelbine—hematologic cancer	5.43e-05	0.0299	CbGdCrCtD
Pralatrexate—TYMS—Vincristine—Vinblastine—hematologic cancer	5.39e-05	0.0297	CbGdCrCtD
Pralatrexate—TYMS—Vinblastine—Vincristine—hematologic cancer	4.34e-05	0.0239	CbGdCrCtD
Pralatrexate—TYMS—Azacitidine—Pentostatin—hematologic cancer	4.11e-05	0.0226	CbGdCrCtD
Pralatrexate—TYMS—Azacitidine—Clofarabine—hematologic cancer	3.67e-05	0.0202	CbGdCrCtD
Pralatrexate—TYMS—Azacitidine—Nelarabine—hematologic cancer	3.45e-05	0.019	CbGdCrCtD
Pralatrexate—Neutropenia—Methotrexate—hematologic cancer	3.41e-05	0.000404	CcSEcCtD
Pralatrexate—Pruritus—Thiotepa—hematologic cancer	3.41e-05	0.000404	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Irinotecan—hematologic cancer	3.4e-05	0.000403	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Mitoxantrone—hematologic cancer	3.4e-05	0.000403	CcSEcCtD
Pralatrexate—Dehydration—Doxorubicin—hematologic cancer	3.4e-05	0.000402	CcSEcCtD
Pralatrexate—Thrombocytopenia—Etoposide—hematologic cancer	3.39e-05	0.000401	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Methotrexate—hematologic cancer	3.39e-05	0.000401	CcSEcCtD
Pralatrexate—Tachycardia—Etoposide—hematologic cancer	3.38e-05	0.0004	CcSEcCtD
Pralatrexate—Abdominal pain—Vincristine—hematologic cancer	3.38e-05	0.0004	CcSEcCtD
Pralatrexate—Body temperature increased—Vincristine—hematologic cancer	3.38e-05	0.0004	CcSEcCtD
Pralatrexate—Liver function test abnormal—Doxorubicin—hematologic cancer	3.37e-05	0.000399	CcSEcCtD
Pralatrexate—Dyspnoea—Cisplatin—hematologic cancer	3.37e-05	0.000399	CcSEcCtD
Pralatrexate—Cough—Triamcinolone—hematologic cancer	3.36e-05	0.000397	CcSEcCtD
Pralatrexate—Asthenia—Thalidomide—hematologic cancer	3.34e-05	0.000396	CcSEcCtD
Pralatrexate—Nausea—Lenalidomide—hematologic cancer	3.33e-05	0.000395	CcSEcCtD
Pralatrexate—Tachycardia—Prednisolone—hematologic cancer	3.33e-05	0.000395	CcSEcCtD
Pralatrexate—Hypokalaemia—Doxorubicin—hematologic cancer	3.32e-05	0.000394	CcSEcCtD
Pralatrexate—Anorexia—Etoposide—hematologic cancer	3.3e-05	0.000391	CcSEcCtD
Pralatrexate—Pruritus—Thalidomide—hematologic cancer	3.3e-05	0.00039	CcSEcCtD
Pralatrexate—Diarrhoea—Thiotepa—hematologic cancer	3.3e-05	0.00039	CcSEcCtD
Pralatrexate—Abdominal pain—Mitoxantrone—hematologic cancer	3.29e-05	0.00039	CcSEcCtD
Pralatrexate—Body temperature increased—Irinotecan—hematologic cancer	3.29e-05	0.00039	CcSEcCtD
Pralatrexate—Abdominal pain—Irinotecan—hematologic cancer	3.29e-05	0.00039	CcSEcCtD
Pralatrexate—Body temperature increased—Mitoxantrone—hematologic cancer	3.29e-05	0.00039	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	3.29e-05	0.000389	CcSEcCtD
Pralatrexate—Nausea—Hydroxyurea—hematologic cancer	3.29e-05	0.000389	CcSEcCtD
Pralatrexate—Vomiting—Bortezomib—hematologic cancer	3.28e-05	0.000389	CcSEcCtD
Pralatrexate—Decreased appetite—Cisplatin—hematologic cancer	3.28e-05	0.000389	CcSEcCtD
Pralatrexate—Vomiting—Bleomycin—hematologic cancer	3.26e-05	0.000386	CcSEcCtD
Pralatrexate—Rash—Bortezomib—hematologic cancer	3.26e-05	0.000386	CcSEcCtD
Pralatrexate—Dermatitis—Bortezomib—hematologic cancer	3.25e-05	0.000385	CcSEcCtD
Pralatrexate—Pancytopenia—Epirubicin—hematologic cancer	3.24e-05	0.000384	CcSEcCtD
Pralatrexate—Rash—Bleomycin—hematologic cancer	3.23e-05	0.000383	CcSEcCtD
Pralatrexate—Dermatitis—Bleomycin—hematologic cancer	3.23e-05	0.000382	CcSEcCtD
Pralatrexate—Asthenia—Carmustine—hematologic cancer	3.21e-05	0.00038	CcSEcCtD
Pralatrexate—Vomiting—Vinorelbine—hematologic cancer	3.21e-05	0.00038	CcSEcCtD
Pralatrexate—Body temperature increased—Gemcitabine—hematologic cancer	3.2e-05	0.000379	CcSEcCtD
Pralatrexate—Neutropenia—Epirubicin—hematologic cancer	3.19e-05	0.000378	CcSEcCtD
Pralatrexate—Diarrhoea—Thalidomide—hematologic cancer	3.19e-05	0.000378	CcSEcCtD
Pralatrexate—Asthenia—Alitretinoin—hematologic cancer	3.18e-05	0.000377	CcSEcCtD
Pralatrexate—Rash—Vinorelbine—hematologic cancer	3.18e-05	0.000377	CcSEcCtD
Pralatrexate—Dermatitis—Vinorelbine—hematologic cancer	3.18e-05	0.000376	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Epirubicin—hematologic cancer	3.17e-05	0.000375	CcSEcCtD
Pralatrexate—Asthenia—Ifosfamide—hematologic cancer	3.14e-05	0.000372	CcSEcCtD
Pralatrexate—Oedema—Triamcinolone—hematologic cancer	3.14e-05	0.000372	CcSEcCtD
Pralatrexate—Pruritus—Alitretinoin—hematologic cancer	3.14e-05	0.000371	CcSEcCtD
Pralatrexate—Pruritus—Ifosfamide—hematologic cancer	3.1e-05	0.000367	CcSEcCtD
Pralatrexate—Dyspnoea—Etoposide—hematologic cancer	3.08e-05	0.000365	CcSEcCtD
Pralatrexate—Nausea—Bortezomib—hematologic cancer	3.07e-05	0.000363	CcSEcCtD
Pralatrexate—Epistaxis—Methotrexate—hematologic cancer	3.07e-05	0.000363	CcSEcCtD
Pralatrexate—Asthenia—Vincristine—hematologic cancer	3.06e-05	0.000363	CcSEcCtD
Pralatrexate—Tachycardia—Triamcinolone—hematologic cancer	3.06e-05	0.000363	CcSEcCtD
Pralatrexate—Vomiting—Thiotepa—hematologic cancer	3.06e-05	0.000363	CcSEcCtD
Pralatrexate—Diarrhoea—Carmustine—hematologic cancer	3.06e-05	0.000363	CcSEcCtD
Pralatrexate—Nausea—Bleomycin—hematologic cancer	3.04e-05	0.000361	CcSEcCtD
Pralatrexate—Rash—Thiotepa—hematologic cancer	3.04e-05	0.00036	CcSEcCtD
Pralatrexate—Dermatitis—Thiotepa—hematologic cancer	3.03e-05	0.000359	CcSEcCtD
Pralatrexate—Diarrhoea—Alitretinoin—hematologic cancer	3.03e-05	0.000359	CcSEcCtD
Pralatrexate—Decreased appetite—Etoposide—hematologic cancer	3.01e-05	0.000356	CcSEcCtD
Pralatrexate—Diarrhoea—Ifosfamide—hematologic cancer	3e-05	0.000355	CcSEcCtD
Pralatrexate—Pancytopenia—Doxorubicin—hematologic cancer	3e-05	0.000355	CcSEcCtD
Pralatrexate—Nausea—Vinorelbine—hematologic cancer	3e-05	0.000355	CcSEcCtD
Pralatrexate—Body temperature increased—Cisplatin—hematologic cancer	2.99e-05	0.000354	CcSEcCtD
Pralatrexate—Asthenia—Mitoxantrone—hematologic cancer	2.98e-05	0.000354	CcSEcCtD
Pralatrexate—Asthenia—Irinotecan—hematologic cancer	2.98e-05	0.000354	CcSEcCtD
Pralatrexate—Fatigue—Etoposide—hematologic cancer	2.98e-05	0.000353	CcSEcCtD
Pralatrexate—Vomiting—Thalidomide—hematologic cancer	2.96e-05	0.000351	CcSEcCtD
Pralatrexate—Constipation—Etoposide—hematologic cancer	2.96e-05	0.00035	CcSEcCtD
Pralatrexate—Neutropenia—Doxorubicin—hematologic cancer	2.95e-05	0.00035	CcSEcCtD
Pralatrexate—Rash—Thalidomide—hematologic cancer	2.94e-05	0.000348	CcSEcCtD
Pralatrexate—Dermatitis—Thalidomide—hematologic cancer	2.93e-05	0.000348	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Doxorubicin—hematologic cancer	2.93e-05	0.000347	CcSEcCtD
Pralatrexate—Diarrhoea—Vincristine—hematologic cancer	2.92e-05	0.000346	CcSEcCtD
Pralatrexate—Asthenia—Gemcitabine—hematologic cancer	2.91e-05	0.000344	CcSEcCtD
Pralatrexate—Epistaxis—Epirubicin—hematologic cancer	2.87e-05	0.00034	CcSEcCtD
Pralatrexate—Pruritus—Gemcitabine—hematologic cancer	2.87e-05	0.00034	CcSEcCtD
Pralatrexate—Nausea—Thiotepa—hematologic cancer	2.86e-05	0.000339	CcSEcCtD
Pralatrexate—Oedema—Dexamethasone—hematologic cancer	2.85e-05	0.000337	CcSEcCtD
Pralatrexate—Oedema—Betamethasone—hematologic cancer	2.85e-05	0.000337	CcSEcCtD
Pralatrexate—Diarrhoea—Mitoxantrone—hematologic cancer	2.85e-05	0.000337	CcSEcCtD
Pralatrexate—Diarrhoea—Irinotecan—hematologic cancer	2.85e-05	0.000337	CcSEcCtD
Pralatrexate—Vomiting—Carmustine—hematologic cancer	2.85e-05	0.000337	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Etoposide—hematologic cancer	2.83e-05	0.000335	CcSEcCtD
Pralatrexate—Rash—Carmustine—hematologic cancer	2.82e-05	0.000334	CcSEcCtD
Pralatrexate—Dermatitis—Carmustine—hematologic cancer	2.82e-05	0.000334	CcSEcCtD
Pralatrexate—Vomiting—Alitretinoin—hematologic cancer	2.82e-05	0.000334	CcSEcCtD
Pralatrexate—Anaemia—Prednisone—hematologic cancer	2.81e-05	0.000333	CcSEcCtD
Pralatrexate—Dyspnoea—Triamcinolone—hematologic cancer	2.8e-05	0.000331	CcSEcCtD
Pralatrexate—Rash—Alitretinoin—hematologic cancer	2.8e-05	0.000331	CcSEcCtD
Pralatrexate—Dermatitis—Alitretinoin—hematologic cancer	2.79e-05	0.000331	CcSEcCtD
Pralatrexate—Thrombocytopenia—Betamethasone—hematologic cancer	2.79e-05	0.00033	CcSEcCtD
Pralatrexate—Thrombocytopenia—Dexamethasone—hematologic cancer	2.79e-05	0.00033	CcSEcCtD
Pralatrexate—Vomiting—Ifosfamide—hematologic cancer	2.79e-05	0.00033	CcSEcCtD
Pralatrexate—Tachycardia—Dexamethasone—hematologic cancer	2.78e-05	0.000329	CcSEcCtD
Pralatrexate—Tachycardia—Betamethasone—hematologic cancer	2.78e-05	0.000329	CcSEcCtD
Pralatrexate—Diarrhoea—Gemcitabine—hematologic cancer	2.77e-05	0.000328	CcSEcCtD
Pralatrexate—Nausea—Thalidomide—hematologic cancer	2.77e-05	0.000328	CcSEcCtD
Pralatrexate—Rash—Ifosfamide—hematologic cancer	2.76e-05	0.000327	CcSEcCtD
Pralatrexate—Dermatitis—Ifosfamide—hematologic cancer	2.76e-05	0.000327	CcSEcCtD
Pralatrexate—Body temperature increased—Etoposide—hematologic cancer	2.74e-05	0.000324	CcSEcCtD
Pralatrexate—Abdominal pain—Etoposide—hematologic cancer	2.74e-05	0.000324	CcSEcCtD
Pralatrexate—Vomiting—Vincristine—hematologic cancer	2.72e-05	0.000322	CcSEcCtD
Pralatrexate—Anorexia—Betamethasone—hematologic cancer	2.71e-05	0.000322	CcSEcCtD
Pralatrexate—Anorexia—Dexamethasone—hematologic cancer	2.71e-05	0.000322	CcSEcCtD
Pralatrexate—Asthenia—Cisplatin—hematologic cancer	2.71e-05	0.000321	CcSEcCtD
Pralatrexate—Fatigue—Triamcinolone—hematologic cancer	2.71e-05	0.00032	CcSEcCtD
Pralatrexate—Rash—Vincristine—hematologic cancer	2.69e-05	0.000319	CcSEcCtD
Pralatrexate—TYMS—Azacitidine—Fludarabine—hematologic cancer	2.69e-05	0.0148	CbGdCrCtD
Pralatrexate—Dermatitis—Vincristine—hematologic cancer	2.69e-05	0.000319	CcSEcCtD
Pralatrexate—Nausea—Carmustine—hematologic cancer	2.66e-05	0.000315	CcSEcCtD
Pralatrexate—Epistaxis—Doxorubicin—hematologic cancer	2.65e-05	0.000314	CcSEcCtD
Pralatrexate—Vomiting—Mitoxantrone—hematologic cancer	2.64e-05	0.000313	CcSEcCtD
Pralatrexate—Vomiting—Irinotecan—hematologic cancer	2.64e-05	0.000313	CcSEcCtD
Pralatrexate—Nausea—Alitretinoin—hematologic cancer	2.63e-05	0.000312	CcSEcCtD
Pralatrexate—Rash—Mitoxantrone—hematologic cancer	2.62e-05	0.000311	CcSEcCtD
Pralatrexate—Rash—Irinotecan—hematologic cancer	2.62e-05	0.000311	CcSEcCtD
Pralatrexate—Dermatitis—Mitoxantrone—hematologic cancer	2.62e-05	0.00031	CcSEcCtD
Pralatrexate—Dermatitis—Irinotecan—hematologic cancer	2.62e-05	0.00031	CcSEcCtD
Pralatrexate—Nausea—Ifosfamide—hematologic cancer	2.6e-05	0.000308	CcSEcCtD
Pralatrexate—Diarrhoea—Cisplatin—hematologic cancer	2.58e-05	0.000306	CcSEcCtD
Pralatrexate—Vomiting—Gemcitabine—hematologic cancer	2.58e-05	0.000305	CcSEcCtD
Pralatrexate—Rash—Gemcitabine—hematologic cancer	2.56e-05	0.000303	CcSEcCtD
Pralatrexate—Dermatitis—Gemcitabine—hematologic cancer	2.55e-05	0.000302	CcSEcCtD
Pralatrexate—TYMS—Azacitidine—Cytarabine—hematologic cancer	2.54e-05	0.014	CbGdCrCtD
Pralatrexate—TYMS—Azacitidine—Gemcitabine—hematologic cancer	2.54e-05	0.014	CbGdCrCtD
Pralatrexate—Nausea—Vincristine—hematologic cancer	2.54e-05	0.000301	CcSEcCtD
Pralatrexate—Asthenia—Etoposide—hematologic cancer	2.48e-05	0.000294	CcSEcCtD
Pralatrexate—Body temperature increased—Triamcinolone—hematologic cancer	2.48e-05	0.000294	CcSEcCtD
Pralatrexate—Oedema—Prednisone—hematologic cancer	2.48e-05	0.000294	CcSEcCtD
Pralatrexate—TYMS—Azacitidine—Cladribine—hematologic cancer	2.48e-05	0.0136	CbGdCrCtD
Pralatrexate—Decreased appetite—Dexamethasone—hematologic cancer	2.48e-05	0.000293	CcSEcCtD
Pralatrexate—Decreased appetite—Betamethasone—hematologic cancer	2.48e-05	0.000293	CcSEcCtD
Pralatrexate—Nausea—Mitoxantrone—hematologic cancer	2.47e-05	0.000293	CcSEcCtD
Pralatrexate—Nausea—Irinotecan—hematologic cancer	2.47e-05	0.000293	CcSEcCtD
Pralatrexate—Back pain—Methotrexate—hematologic cancer	2.46e-05	0.000291	CcSEcCtD
Pralatrexate—Fatigue—Betamethasone—hematologic cancer	2.46e-05	0.000291	CcSEcCtD
Pralatrexate—Fatigue—Dexamethasone—hematologic cancer	2.46e-05	0.000291	CcSEcCtD
Pralatrexate—Pruritus—Etoposide—hematologic cancer	2.45e-05	0.00029	CcSEcCtD
Pralatrexate—Tachycardia—Prednisone—hematologic cancer	2.42e-05	0.000287	CcSEcCtD
Pralatrexate—Nausea—Gemcitabine—hematologic cancer	2.41e-05	0.000285	CcSEcCtD
Pralatrexate—Vomiting—Cisplatin—hematologic cancer	2.4e-05	0.000284	CcSEcCtD
Pralatrexate—Methotrexate—ALB—hematologic cancer	2.4e-05	0.00895	CrCbGaD
Pralatrexate—Rash—Cisplatin—hematologic cancer	2.38e-05	0.000282	CcSEcCtD
Pralatrexate—Dermatitis—Cisplatin—hematologic cancer	2.38e-05	0.000282	CcSEcCtD
Pralatrexate—Diarrhoea—Etoposide—hematologic cancer	2.37e-05	0.00028	CcSEcCtD
Pralatrexate—Anorexia—Prednisone—hematologic cancer	2.36e-05	0.00028	CcSEcCtD
Pralatrexate—Anaemia—Methotrexate—hematologic cancer	2.35e-05	0.000278	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Betamethasone—hematologic cancer	2.33e-05	0.000276	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.33e-05	0.000276	CcSEcCtD
Pralatrexate—Back pain—Epirubicin—hematologic cancer	2.3e-05	0.000272	CcSEcCtD
Pralatrexate—Methotrexate—ABCB1—hematologic cancer	2.29e-05	0.00854	CrCbGaD
Pralatrexate—Leukopenia—Methotrexate—hematologic cancer	2.27e-05	0.000269	CcSEcCtD
Pralatrexate—Asthenia—Triamcinolone—hematologic cancer	2.25e-05	0.000267	CcSEcCtD
Pralatrexate—Body temperature increased—Betamethasone—hematologic cancer	2.25e-05	0.000267	CcSEcCtD
Pralatrexate—Abdominal pain—Dexamethasone—hematologic cancer	2.25e-05	0.000267	CcSEcCtD
Pralatrexate—Body temperature increased—Dexamethasone—hematologic cancer	2.25e-05	0.000267	CcSEcCtD
Pralatrexate—Abdominal pain—Betamethasone—hematologic cancer	2.25e-05	0.000267	CcSEcCtD
Pralatrexate—Nausea—Cisplatin—hematologic cancer	2.24e-05	0.000266	CcSEcCtD
Pralatrexate—Pruritus—Triamcinolone—hematologic cancer	2.22e-05	0.000263	CcSEcCtD
Pralatrexate—Cough—Methotrexate—hematologic cancer	2.22e-05	0.000262	CcSEcCtD
Pralatrexate—Vomiting—Etoposide—hematologic cancer	2.2e-05	0.000261	CcSEcCtD
Pralatrexate—Anaemia—Epirubicin—hematologic cancer	2.2e-05	0.00026	CcSEcCtD
Pralatrexate—Rash—Etoposide—hematologic cancer	2.18e-05	0.000258	CcSEcCtD
Pralatrexate—Dermatitis—Etoposide—hematologic cancer	2.18e-05	0.000258	CcSEcCtD
Pralatrexate—Decreased appetite—Prednisone—hematologic cancer	2.16e-05	0.000255	CcSEcCtD
Pralatrexate—Rash—Prednisolone—hematologic cancer	2.15e-05	0.000255	CcSEcCtD
Pralatrexate—Dermatitis—Prednisolone—hematologic cancer	2.15e-05	0.000255	CcSEcCtD
Pralatrexate—Fatigue—Prednisone—hematologic cancer	2.14e-05	0.000253	CcSEcCtD
Pralatrexate—Leukopenia—Epirubicin—hematologic cancer	2.13e-05	0.000252	CcSEcCtD
Pralatrexate—Back pain—Doxorubicin—hematologic cancer	2.13e-05	0.000252	CcSEcCtD
Pralatrexate—Constipation—Prednisone—hematologic cancer	2.12e-05	0.000251	CcSEcCtD
Pralatrexate—Cough—Epirubicin—hematologic cancer	2.07e-05	0.000246	CcSEcCtD
Pralatrexate—Nausea—Etoposide—hematologic cancer	2.06e-05	0.000243	CcSEcCtD
Pralatrexate—Asthenia—Dexamethasone—hematologic cancer	2.04e-05	0.000242	CcSEcCtD
Pralatrexate—Asthenia—Betamethasone—hematologic cancer	2.04e-05	0.000242	CcSEcCtD
Pralatrexate—Anaemia—Doxorubicin—hematologic cancer	2.03e-05	0.000241	CcSEcCtD
Pralatrexate—Thrombocytopenia—Methotrexate—hematologic cancer	2.03e-05	0.00024	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Prednisone—hematologic cancer	2.03e-05	0.00024	CcSEcCtD
Pralatrexate—Nausea—Prednisolone—hematologic cancer	2.03e-05	0.00024	CcSEcCtD
Pralatrexate—Pruritus—Betamethasone—hematologic cancer	2.01e-05	0.000239	CcSEcCtD
Pralatrexate—Pruritus—Dexamethasone—hematologic cancer	2.01e-05	0.000239	CcSEcCtD
Pralatrexate—Vomiting—Triamcinolone—hematologic cancer	2e-05	0.000236	CcSEcCtD
Pralatrexate—Rash—Triamcinolone—hematologic cancer	1.98e-05	0.000234	CcSEcCtD
Pralatrexate—Dermatitis—Triamcinolone—hematologic cancer	1.98e-05	0.000234	CcSEcCtD
Pralatrexate—Anorexia—Methotrexate—hematologic cancer	1.98e-05	0.000234	CcSEcCtD
Pralatrexate—Leukopenia—Doxorubicin—hematologic cancer	1.97e-05	0.000233	CcSEcCtD
Pralatrexate—Body temperature increased—Prednisone—hematologic cancer	1.96e-05	0.000232	CcSEcCtD
Pralatrexate—Abdominal pain—Prednisone—hematologic cancer	1.96e-05	0.000232	CcSEcCtD
Pralatrexate—Diarrhoea—Betamethasone—hematologic cancer	1.95e-05	0.000231	CcSEcCtD
Pralatrexate—Diarrhoea—Dexamethasone—hematologic cancer	1.95e-05	0.000231	CcSEcCtD
Pralatrexate—Oedema—Epirubicin—hematologic cancer	1.94e-05	0.00023	CcSEcCtD
Pralatrexate—Cough—Doxorubicin—hematologic cancer	1.92e-05	0.000227	CcSEcCtD
Pralatrexate—Thrombocytopenia—Epirubicin—hematologic cancer	1.9e-05	0.000225	CcSEcCtD
Pralatrexate—Tachycardia—Epirubicin—hematologic cancer	1.89e-05	0.000224	CcSEcCtD
Pralatrexate—Nausea—Triamcinolone—hematologic cancer	1.86e-05	0.000221	CcSEcCtD
Pralatrexate—Anorexia—Epirubicin—hematologic cancer	1.85e-05	0.000219	CcSEcCtD
Pralatrexate—Dyspnoea—Methotrexate—hematologic cancer	1.85e-05	0.000219	CcSEcCtD
Pralatrexate—Vomiting—Dexamethasone—hematologic cancer	1.81e-05	0.000214	CcSEcCtD
Pralatrexate—Vomiting—Betamethasone—hematologic cancer	1.81e-05	0.000214	CcSEcCtD
Pralatrexate—Decreased appetite—Methotrexate—hematologic cancer	1.8e-05	0.000213	CcSEcCtD
Pralatrexate—Rash—Dexamethasone—hematologic cancer	1.8e-05	0.000213	CcSEcCtD
Pralatrexate—Rash—Betamethasone—hematologic cancer	1.8e-05	0.000213	CcSEcCtD
Pralatrexate—Oedema—Doxorubicin—hematologic cancer	1.79e-05	0.000213	CcSEcCtD
Pralatrexate—Dermatitis—Dexamethasone—hematologic cancer	1.79e-05	0.000212	CcSEcCtD
Pralatrexate—Dermatitis—Betamethasone—hematologic cancer	1.79e-05	0.000212	CcSEcCtD
Pralatrexate—Fatigue—Methotrexate—hematologic cancer	1.79e-05	0.000212	CcSEcCtD
Pralatrexate—Asthenia—Prednisone—hematologic cancer	1.78e-05	0.000211	CcSEcCtD
Pralatrexate—Thrombocytopenia—Doxorubicin—hematologic cancer	1.76e-05	0.000208	CcSEcCtD
Pralatrexate—Pruritus—Prednisone—hematologic cancer	1.75e-05	0.000208	CcSEcCtD
Pralatrexate—Tachycardia—Doxorubicin—hematologic cancer	1.75e-05	0.000207	CcSEcCtD
Pralatrexate—Dyspnoea—Epirubicin—hematologic cancer	1.73e-05	0.000205	CcSEcCtD
Pralatrexate—Anorexia—Doxorubicin—hematologic cancer	1.71e-05	0.000203	CcSEcCtD
Pralatrexate—Diarrhoea—Prednisone—hematologic cancer	1.7e-05	0.000201	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Methotrexate—hematologic cancer	1.69e-05	0.000201	CcSEcCtD
Pralatrexate—Nausea—Betamethasone—hematologic cancer	1.69e-05	0.0002	CcSEcCtD
Pralatrexate—Nausea—Dexamethasone—hematologic cancer	1.69e-05	0.0002	CcSEcCtD
Pralatrexate—Decreased appetite—Epirubicin—hematologic cancer	1.69e-05	0.0002	CcSEcCtD
Pralatrexate—Fatigue—Epirubicin—hematologic cancer	1.67e-05	0.000198	CcSEcCtD
Pralatrexate—Constipation—Epirubicin—hematologic cancer	1.66e-05	0.000196	CcSEcCtD
Pralatrexate—Body temperature increased—Methotrexate—hematologic cancer	1.64e-05	0.000194	CcSEcCtD
Pralatrexate—Abdominal pain—Methotrexate—hematologic cancer	1.64e-05	0.000194	CcSEcCtD
Pralatrexate—Dyspnoea—Doxorubicin—hematologic cancer	1.6e-05	0.00019	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.59e-05	0.000188	CcSEcCtD
Pralatrexate—Vomiting—Prednisone—hematologic cancer	1.58e-05	0.000187	CcSEcCtD
Pralatrexate—TYMS—Clobetasol propionate—Dexamethasone—hematologic cancer	1.57e-05	0.00861	CbGdCrCtD
Pralatrexate—TYMS—Clobetasol propionate—Betamethasone—hematologic cancer	1.57e-05	0.00861	CbGdCrCtD
Pralatrexate—Rash—Prednisone—hematologic cancer	1.56e-05	0.000185	CcSEcCtD
Pralatrexate—Dermatitis—Prednisone—hematologic cancer	1.56e-05	0.000185	CcSEcCtD
Pralatrexate—Decreased appetite—Doxorubicin—hematologic cancer	1.56e-05	0.000185	CcSEcCtD
Pralatrexate—Fatigue—Doxorubicin—hematologic cancer	1.55e-05	0.000183	CcSEcCtD
Pralatrexate—TYMS—Flunisolide—Dexamethasone—hematologic cancer	1.54e-05	0.0085	CbGdCrCtD
Pralatrexate—TYMS—Flunisolide—Betamethasone—hematologic cancer	1.54e-05	0.0085	CbGdCrCtD
Pralatrexate—Constipation—Doxorubicin—hematologic cancer	1.53e-05	0.000182	CcSEcCtD
Pralatrexate—Body temperature increased—Epirubicin—hematologic cancer	1.53e-05	0.000182	CcSEcCtD
Pralatrexate—Abdominal pain—Epirubicin—hematologic cancer	1.53e-05	0.000182	CcSEcCtD
Pralatrexate—TYMS—Clobetasol propionate—Triamcinolone—hematologic cancer	1.53e-05	0.00842	CbGdCrCtD
Pralatrexate—TYMS—Triamcinolone—Dexamethasone—hematologic cancer	1.53e-05	0.00842	CbGdCrCtD
Pralatrexate—TYMS—Triamcinolone—Betamethasone—hematologic cancer	1.53e-05	0.00842	CbGdCrCtD
Pralatrexate—TYMS—Flunisolide—Triamcinolone—hematologic cancer	1.51e-05	0.00831	CbGdCrCtD
Pralatrexate—TYMS—Fluticasone Propionate—Dexamethasone—hematologic cancer	1.49e-05	0.00821	CbGdCrCtD
Pralatrexate—TYMS—Fluticasone Propionate—Betamethasone—hematologic cancer	1.49e-05	0.00821	CbGdCrCtD
Pralatrexate—Asthenia—Methotrexate—hematologic cancer	1.49e-05	0.000176	CcSEcCtD
Pralatrexate—Nausea—Prednisone—hematologic cancer	1.47e-05	0.000174	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.47e-05	0.000174	CcSEcCtD
Pralatrexate—Pruritus—Methotrexate—hematologic cancer	1.47e-05	0.000174	CcSEcCtD
Pralatrexate—TYMS—Fluticasone Propionate—Triamcinolone—hematologic cancer	1.46e-05	0.00802	CbGdCrCtD
Pralatrexate—TYMS—Clobetasol propionate—Prednisone—hematologic cancer	1.45e-05	0.00799	CbGdCrCtD
Pralatrexate—TYMS—Flunisolide—Prednisone—hematologic cancer	1.43e-05	0.00788	CbGdCrCtD
Pralatrexate—Body temperature increased—Doxorubicin—hematologic cancer	1.42e-05	0.000168	CcSEcCtD
Pralatrexate—Abdominal pain—Doxorubicin—hematologic cancer	1.42e-05	0.000168	CcSEcCtD
Pralatrexate—Diarrhoea—Methotrexate—hematologic cancer	1.42e-05	0.000168	CcSEcCtD
Pralatrexate—TYMS—Triamcinolone—Prednisone—hematologic cancer	1.42e-05	0.0078	CbGdCrCtD
Pralatrexate—TYMS—Clobetasol propionate—Prednisolone—hematologic cancer	1.42e-05	0.0078	CbGdCrCtD
Pralatrexate—TYMS—Diflorasone—Dexamethasone—hematologic cancer	1.41e-05	0.00776	CbGdCrCtD
Pralatrexate—TYMS—Diflorasone—Betamethasone—hematologic cancer	1.41e-05	0.00776	CbGdCrCtD
Pralatrexate—TYMS—Flunisolide—Prednisolone—hematologic cancer	1.4e-05	0.0077	CbGdCrCtD
Pralatrexate—Asthenia—Epirubicin—hematologic cancer	1.39e-05	0.000165	CcSEcCtD
Pralatrexate—TYMS—Triamcinolone—Prednisolone—hematologic cancer	1.38e-05	0.00762	CbGdCrCtD
Pralatrexate—TYMS—Diflorasone—Triamcinolone—hematologic cancer	1.38e-05	0.00758	CbGdCrCtD
Pralatrexate—Pruritus—Epirubicin—hematologic cancer	1.37e-05	0.000163	CcSEcCtD
Pralatrexate—Diarrhoea—Epirubicin—hematologic cancer	1.33e-05	0.000157	CcSEcCtD
Pralatrexate—Vomiting—Methotrexate—hematologic cancer	1.32e-05	0.000156	CcSEcCtD
Pralatrexate—TYMS—Diflorasone—Prednisone—hematologic cancer	1.31e-05	0.00719	CbGdCrCtD
Pralatrexate—Rash—Methotrexate—hematologic cancer	1.31e-05	0.000155	CcSEcCtD
Pralatrexate—Dermatitis—Methotrexate—hematologic cancer	1.31e-05	0.000155	CcSEcCtD
Pralatrexate—Asthenia—Doxorubicin—hematologic cancer	1.29e-05	0.000153	CcSEcCtD
Pralatrexate—TYMS—Diflorasone—Prednisolone—hematologic cancer	1.28e-05	0.00702	CbGdCrCtD
Pralatrexate—Pruritus—Doxorubicin—hematologic cancer	1.27e-05	0.00015	CcSEcCtD
Pralatrexate—SLC19A1—Disease—MTOR—hematologic cancer	1.27e-05	0.000252	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.27e-05	0.000252	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD4—hematologic cancer	1.27e-05	0.000252	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—UGT1A1—hematologic cancer	1.26e-05	0.000251	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ACP5—hematologic cancer	1.26e-05	0.000251	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CA9—hematologic cancer	1.26e-05	0.000251	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK2—hematologic cancer	1.26e-05	0.00025	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAP2K1—hematologic cancer	1.25e-05	0.000248	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOR2—hematologic cancer	1.24e-05	0.000247	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CD—hematologic cancer	1.24e-05	0.000246	CbGpPWpGaD
Pralatrexate—TYMS—Budesonide—Dexamethasone—hematologic cancer	1.24e-05	0.0068	CbGdCrCtD
Pralatrexate—TYMS—Budesonide—Betamethasone—hematologic cancer	1.24e-05	0.0068	CbGdCrCtD
Pralatrexate—Vomiting—Epirubicin—hematologic cancer	1.23e-05	0.000146	CcSEcCtD
Pralatrexate—Nausea—Methotrexate—hematologic cancer	1.23e-05	0.000146	CcSEcCtD
Pralatrexate—DHFR—Metabolism—CRABP1—hematologic cancer	1.23e-05	0.000244	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SLC22A1—hematologic cancer	1.23e-05	0.000244	CbGpPWpGaD
Pralatrexate—Diarrhoea—Doxorubicin—hematologic cancer	1.23e-05	0.000145	CcSEcCtD
Pralatrexate—TYMS—Cell Cycle—BIRC5—hematologic cancer	1.23e-05	0.000244	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—ATM—hematologic cancer	1.22e-05	0.000243	CbGpPWpGaD
Pralatrexate—Rash—Epirubicin—hematologic cancer	1.22e-05	0.000145	CcSEcCtD
Pralatrexate—Dermatitis—Epirubicin—hematologic cancer	1.22e-05	0.000145	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—PIK3CD—hematologic cancer	1.22e-05	0.000242	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDK4—hematologic cancer	1.22e-05	0.000242	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SDC1—hematologic cancer	1.22e-05	0.000242	CbGpPWpGaD
Pralatrexate—TYMS—Budesonide—Triamcinolone—hematologic cancer	1.21e-05	0.00664	CbGdCrCtD
Pralatrexate—SLC19A1—Metabolism—ALB—hematologic cancer	1.2e-05	0.000239	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALOX5—hematologic cancer	1.2e-05	0.000238	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1B—hematologic cancer	1.19e-05	0.000237	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.19e-05	0.000236	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TERT—hematologic cancer	1.19e-05	0.000236	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—IDH1—hematologic cancer	1.19e-05	0.000236	CbGpPWpGaD
Pralatrexate—FPGS—Disease—FGF2—hematologic cancer	1.19e-05	0.000235	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.18e-05	0.000235	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RB1—hematologic cancer	1.18e-05	0.000235	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000234	CbGpPWpGaD
Pralatrexate—DHFR—Disease—LCK—hematologic cancer	1.18e-05	0.000234	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.18e-05	0.000233	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCC3—hematologic cancer	1.17e-05	0.000233	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—TXN—hematologic cancer	1.17e-05	0.000233	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTO1—hematologic cancer	1.17e-05	0.000233	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3R1—hematologic cancer	1.17e-05	0.000232	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NUP98—hematologic cancer	1.16e-05	0.00023	CbGpPWpGaD
Pralatrexate—DHFR—Disease—H3F3A—hematologic cancer	1.15e-05	0.000229	CbGpPWpGaD
Pralatrexate—Nausea—Epirubicin—hematologic cancer	1.15e-05	0.000136	CcSEcCtD
Pralatrexate—SLC19A1—Metabolism—PIK3R1—hematologic cancer	1.15e-05	0.000229	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SPHK1—hematologic cancer	1.15e-05	0.000228	CbGpPWpGaD
Pralatrexate—TYMS—Budesonide—Prednisone—hematologic cancer	1.15e-05	0.00631	CbGdCrCtD
Pralatrexate—Vomiting—Doxorubicin—hematologic cancer	1.14e-05	0.000135	CcSEcCtD
Pralatrexate—FPGS—Disease—JAK2—hematologic cancer	1.14e-05	0.000226	CbGpPWpGaD
Pralatrexate—Rash—Doxorubicin—hematologic cancer	1.13e-05	0.000134	CcSEcCtD
Pralatrexate—Dermatitis—Doxorubicin—hematologic cancer	1.13e-05	0.000134	CcSEcCtD
Pralatrexate—DHFR—Metabolism—ADCY7—hematologic cancer	1.13e-05	0.000224	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOA3—hematologic cancer	1.13e-05	0.000224	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK2—hematologic cancer	1.12e-05	0.000223	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PRKCZ—hematologic cancer	1.12e-05	0.000223	CbGpPWpGaD
Pralatrexate—TYMS—Budesonide—Prednisolone—hematologic cancer	1.12e-05	0.00615	CbGdCrCtD
Pralatrexate—DHFR—Metabolism—NUP214—hematologic cancer	1.12e-05	0.000222	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MDM2—hematologic cancer	1.11e-05	0.00022	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CALR—hematologic cancer	1.1e-05	0.000219	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—UGT1A1—hematologic cancer	1.1e-05	0.000219	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—hematologic cancer	1.1e-05	0.000218	CbGpPWpGaD
Pralatrexate—TYMS—Danazol—Prednisone—hematologic cancer	1.1e-05	0.00604	CbGdCrCtD
Pralatrexate—SLC19A1—Disease—PTEN—hematologic cancer	1.1e-05	0.000218	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCG2—hematologic cancer	1.09e-05	0.000218	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTR—hematologic cancer	1.09e-05	0.000218	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—CREBBP—hematologic cancer	1.09e-05	0.000217	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PARP1—hematologic cancer	1.08e-05	0.000215	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.08e-05	0.000215	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CB—hematologic cancer	1.08e-05	0.000214	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MTOR—hematologic cancer	1.08e-05	0.000214	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD4—hematologic cancer	1.08e-05	0.000214	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ENO2—hematologic cancer	1.07e-05	0.000213	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SLC22A1—hematologic cancer	1.07e-05	0.000213	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CRABP1—hematologic cancer	1.07e-05	0.000213	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—ATM—hematologic cancer	1.07e-05	0.000212	CbGpPWpGaD
Pralatrexate—Nausea—Doxorubicin—hematologic cancer	1.07e-05	0.000126	CcSEcCtD
Pralatrexate—DHFR—Disease—FBXW7—hematologic cancer	1.07e-05	0.000212	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDK4—hematologic cancer	1.06e-05	0.000211	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CB—hematologic cancer	1.06e-05	0.000211	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RB1—hematologic cancer	1.06e-05	0.00021	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EP300—hematologic cancer	1.05e-05	0.000208	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CXCR4—hematologic cancer	1.05e-05	0.000208	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HDAC2—hematologic cancer	1.05e-05	0.000208	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALOX5—hematologic cancer	1.04e-05	0.000208	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.04e-05	0.000208	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTT1—hematologic cancer	1.04e-05	0.000207	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.04e-05	0.000207	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000206	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RB1—hematologic cancer	1.03e-05	0.000205	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD44—hematologic cancer	1.03e-05	0.000205	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—hematologic cancer	1.02e-05	0.000203	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CBL—hematologic cancer	1.02e-05	0.000202	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SDC1—hematologic cancer	1.02e-05	0.000202	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SRC—hematologic cancer	1.02e-05	0.000202	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1B—hematologic cancer	1.01e-05	0.000201	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NUP98—hematologic cancer	1.01e-05	0.000201	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—hematologic cancer	1e-05	0.000199	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ADCY7—hematologic cancer	9.82e-06	0.000195	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOA3—hematologic cancer	9.82e-06	0.000195	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—STAT3—hematologic cancer	9.81e-06	0.000195	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3R1—hematologic cancer	9.79e-06	0.000195	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NRAS—hematologic cancer	9.78e-06	0.000194	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NUP214—hematologic cancer	9.75e-06	0.000194	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HSP90AA1—hematologic cancer	9.72e-06	0.000193	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTR—hematologic cancer	9.55e-06	0.00019	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCG2—hematologic cancer	9.55e-06	0.00019	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT1—hematologic cancer	9.37e-06	0.000186	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ENO2—hematologic cancer	9.37e-06	0.000186	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MAPK3—hematologic cancer	9.37e-06	0.000186	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—hematologic cancer	9.34e-06	0.000186	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTEN—hematologic cancer	9.32e-06	0.000185	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—hematologic cancer	9.31e-06	0.000185	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RB1—hematologic cancer	9.24e-06	0.000184	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	9.22e-06	0.000183	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTEN—hematologic cancer	9.18e-06	0.000182	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—hematologic cancer	9.18e-06	0.000182	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MYC—hematologic cancer	9.11e-06	0.000181	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—hematologic cancer	9.09e-06	0.000181	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTT1—hematologic cancer	9.09e-06	0.000181	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	9.09e-06	0.000181	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CB—hematologic cancer	9.04e-06	0.00018	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MDM2—hematologic cancer	9.03e-06	0.000179	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EP300—hematologic cancer	8.89e-06	0.000177	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SDC1—hematologic cancer	8.88e-06	0.000176	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.82e-06	0.000175	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CCND1—hematologic cancer	8.8e-06	0.000175	CbGpPWpGaD
Pralatrexate—DHFR—Disease—GRB2—hematologic cancer	8.77e-06	0.000174	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—EP300—hematologic cancer	8.76e-06	0.000174	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFA—hematologic cancer	8.75e-06	0.000174	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CD44—hematologic cancer	8.66e-06	0.000172	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NQO1—hematologic cancer	8.66e-06	0.000172	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SRC—hematologic cancer	8.65e-06	0.000172	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KITLG—hematologic cancer	8.62e-06	0.000171	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	8.51e-06	0.000169	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT5A—hematologic cancer	8.43e-06	0.000167	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—KRAS—hematologic cancer	8.42e-06	0.000167	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN2B—hematologic cancer	8.35e-06	0.000166	CbGpPWpGaD
Pralatrexate—FPGS—Disease—STAT3—hematologic cancer	8.34e-06	0.000166	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NRAS—hematologic cancer	8.32e-06	0.000165	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1B—hematologic cancer	8.25e-06	0.000164	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CYCS—hematologic cancer	8.19e-06	0.000163	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—HSP90AA1—hematologic cancer	8.14e-06	0.000162	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—hematologic cancer	8.12e-06	0.000161	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—EP300—hematologic cancer	8.1e-06	0.000161	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD86—hematologic cancer	8.08e-06	0.00016	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	8.05e-06	0.00016	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HES1—hematologic cancer	7.97e-06	0.000158	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MAPK3—hematologic cancer	7.97e-06	0.000158	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NCOR1—hematologic cancer	7.92e-06	0.000157	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MDM2—hematologic cancer	7.88e-06	0.000157	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CCND1—hematologic cancer	7.87e-06	0.000156	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF1—hematologic cancer	7.83e-06	0.000156	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTEN—hematologic cancer	7.81e-06	0.000155	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MYC—hematologic cancer	7.75e-06	0.000154	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PIK3CA—hematologic cancer	7.74e-06	0.000154	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—hematologic cancer	7.73e-06	0.000154	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FOXO1—hematologic cancer	7.72e-06	0.000153	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFRB—hematologic cancer	7.71e-06	0.000153	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CCND1—hematologic cancer	7.68e-06	0.000153	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—hematologic cancer	7.61e-06	0.000151	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFRA—hematologic cancer	7.59e-06	0.000151	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PRKCG—hematologic cancer	7.56e-06	0.00015	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JAK1—hematologic cancer	7.56e-06	0.00015	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CD44—hematologic cancer	7.55e-06	0.00015	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NQO1—hematologic cancer	7.55e-06	0.00015	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—EP300—hematologic cancer	7.45e-06	0.000148	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	7.43e-06	0.000148	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MAPK3—hematologic cancer	7.25e-06	0.000144	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—EP300—hematologic cancer	7.24e-06	0.000144	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTP1—hematologic cancer	7.22e-06	0.000143	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1B—hematologic cancer	7.19e-06	0.000143	CbGpPWpGaD
Pralatrexate—FPGS—Disease—KRAS—hematologic cancer	7.16e-06	0.000142	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—HRAS—hematologic cancer	7.16e-06	0.000142	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CYCS—hematologic cancer	7.15e-06	0.000142	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—HSP90AA1—hematologic cancer	7.1e-06	0.000141	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—EP300—hematologic cancer	7.07e-06	0.00014	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—MYC—hematologic cancer	7.06e-06	0.00014	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTHFR—hematologic cancer	7e-06	0.000139	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TERT—hematologic cancer	6.98e-06	0.000139	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HLA-A—hematologic cancer	6.98e-06	0.000139	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CCND1—hematologic cancer	6.86e-06	0.000136	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—hematologic cancer	6.85e-06	0.000136	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCB1—hematologic cancer	6.83e-06	0.000136	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PDGFB—hematologic cancer	6.81e-06	0.000135	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TSC2—hematologic cancer	6.66e-06	0.000132	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—hematologic cancer	6.64e-06	0.000132	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GSTM1—hematologic cancer	6.63e-06	0.000132	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NCOR1—hematologic cancer	6.63e-06	0.000132	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PIK3CA—hematologic cancer	6.58e-06	0.000131	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MAPK3—hematologic cancer	6.49e-06	0.000129	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PIK3CA—hematologic cancer	6.48e-06	0.000129	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGFR3—hematologic cancer	6.41e-06	0.000127	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MAPK3—hematologic cancer	6.33e-06	0.000126	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—AKT1—hematologic cancer	6.32e-06	0.000126	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—EP300—hematologic cancer	6.32e-06	0.000126	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—MYC—hematologic cancer	6.31e-06	0.000125	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTP1—hematologic cancer	6.3e-06	0.000125	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—MYC—hematologic cancer	6.16e-06	0.000122	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HRAS—hematologic cancer	6.09e-06	0.000121	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BAD—hematologic cancer	6.07e-06	0.000121	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOTCH1—hematologic cancer	6.01e-06	0.00012	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCB1—hematologic cancer	5.96e-06	0.000118	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD80—hematologic cancer	5.89e-06	0.000117	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KIT—hematologic cancer	5.88e-06	0.000117	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MTHFR—hematologic cancer	5.86e-06	0.000116	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—hematologic cancer	5.82e-06	0.000116	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GSTM1—hematologic cancer	5.79e-06	0.000115	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NCOR1—hematologic cancer	5.79e-06	0.000115	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTPN11—hematologic cancer	5.78e-06	0.000115	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MAPK3—hematologic cancer	5.66e-06	0.000112	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CREB1—hematologic cancer	5.6e-06	0.000111	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BRAF—hematologic cancer	5.53e-06	0.00011	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PIK3CA—hematologic cancer	5.51e-06	0.000109	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—MYC—hematologic cancer	5.51e-06	0.000109	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6R—hematologic cancer	5.46e-06	0.000109	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CREBBP—hematologic cancer	5.45e-06	0.000108	CbGpPWpGaD
Pralatrexate—FPGS—Disease—AKT1—hematologic cancer	5.37e-06	0.000107	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—AKT1—hematologic cancer	5.29e-06	0.000105	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAP2K1—hematologic cancer	5.21e-06	0.000103	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—hematologic cancer	5.18e-06	0.000103	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CD—hematologic cancer	5.17e-06	0.000103	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MTHFR—hematologic cancer	5.12e-06	0.000102	CbGpPWpGaD
Pralatrexate—DHFR—Disease—FGF2—hematologic cancer	4.95e-06	9.84e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CG—hematologic cancer	4.93e-06	9.79e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3R1—hematologic cancer	4.88e-06	9.7e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JAK2—hematologic cancer	4.75e-06	9.43e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MDM2—hematologic cancer	4.63e-06	9.2e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—CREBBP—hematologic cancer	4.57e-06	9.07e-05	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—hematologic cancer	4.52e-06	8.98e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CB—hematologic cancer	4.51e-06	8.96e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MTOR—hematologic cancer	4.51e-06	8.96e-05	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—AKT1—hematologic cancer	4.5e-06	8.94e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD4—hematologic cancer	4.5e-06	8.94e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CD—hematologic cancer	4.33e-06	8.6e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CG—hematologic cancer	4.3e-06	8.54e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—hematologic cancer	4.28e-06	8.49e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1B—hematologic cancer	4.23e-06	8.4e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3R1—hematologic cancer	4.09e-06	8.13e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—CREBBP—hematologic cancer	3.99e-06	7.92e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—hematologic cancer	3.9e-06	7.76e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTEN—hematologic cancer	3.89e-06	7.74e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CD—hematologic cancer	3.78e-06	7.51e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CB—hematologic cancer	3.77e-06	7.5e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—hematologic cancer	3.73e-06	7.41e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EP300—hematologic cancer	3.71e-06	7.38e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SRC—hematologic cancer	3.61e-06	7.18e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3R1—hematologic cancer	3.57e-06	7.09e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—STAT3—hematologic cancer	3.48e-06	6.92e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NRAS—hematologic cancer	3.47e-06	6.9e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MAPK3—hematologic cancer	3.33e-06	6.61e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CB—hematologic cancer	3.29e-06	6.54e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTEN—hematologic cancer	3.26e-06	6.48e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MYC—hematologic cancer	3.24e-06	6.43e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—hematologic cancer	3.23e-06	6.42e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—EP300—hematologic cancer	3.11e-06	6.18e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—KRAS—hematologic cancer	2.99e-06	5.94e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTEN—hematologic cancer	2.85e-06	5.65e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PIK3CA—hematologic cancer	2.75e-06	5.46e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—EP300—hematologic cancer	2.71e-06	5.39e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HRAS—hematologic cancer	2.54e-06	5.05e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—hematologic cancer	2.43e-06	4.83e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PIK3CA—hematologic cancer	2.3e-06	4.57e-05	CbGpPWpGaD
Pralatrexate—DHFR—Disease—AKT1—hematologic cancer	2.24e-06	4.46e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PIK3CA—hematologic cancer	2.01e-06	3.99e-05	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—AKT1—hematologic cancer	1.88e-06	3.73e-05	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—AKT1—hematologic cancer	1.64e-06	3.26e-05	CbGpPWpGaD
